Rating History for LENZ Therapeutics Inc (LENZ) by BofA Securities
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/12/2026 | Jason Gerberry | Downgrade | Neutral (Buy) |
7.00 (31.00) |
5.21 (4.52) |
-13.24% | Details |
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/12/2026 | Jason Gerberry | Downgrade | Neutral (Buy) |
7.00 (31.00) |
5.21 (4.52) |
-13.24% | Details |
![]() |
|||||||
![]() |
|||||||